To promote the research and education of antimicrobial peptides (AMPs), the APD now welcomes your submission of AMP news on your research. Please email a link for the news to Dr. Wang (email: gwang@unmc.edu). Due to the global impact of SARS-CoV-2, more attention has been paid to antiviral peptide news.
Dec 22, 2023: Scorpion venom peptides inhibit SARS-CoV-2 at IC50 of 200 nM. See AP03940
May 2023: Novel Polymyxin-Inspired Peptidomimetics Targeting the SARS-CoV-2 Spike:hACE2 Interface
Nov 15, 2022: In silico identification of SARS-Cov-2 peptide inhibitors
Oct 22, 2022: Vitamin D enhances type I IFN signaling in COVID-19 patients
April 25, 2022: Improved database filtering technology succeeded in designing ab initio antiviral peptides against Zika viruses and SARS-Cov-2
June 26, 2021: Human defensins HNPs1-3, HD5, and a theta-defensin RC101 inhibit SARS-COV2 via blocking viral entry
May 28, 2020: Vitamin D deficiency and air pollution worsen COVID-19 due to suppressing LL-37
May 11, 2020: Expression of LL-37 to treat COVID-19 patients (Not reviewed manuscript)
April 1, 2020: Lectin-like Intestinal Defensin HD5 Inhibits 2019-nCoV (SARS-CoV2) Spike binding to the ACE2 receptor (unreviewed report)
March 22, 2020: Engineered human cathelicidin LL-37 peptides inhibit Ebola virus infection
March 3, 2020: Opossum Cathelicidins Exhibit Activity Against West Nile Virus
Jun 17, 2019: Low cationicity is important for systemic in vivo efficacy of database designed peptides against MRSA
Jan 10, 2018: A new gel against deadly, drug-resistant superbugs
Jan 10, 2018: LL-37 inhibits Zika virus
April 21, 2017: Frog Urumin against influenza A virus H1N1
April 17, 2017: Potential Antibiotic from a Dragon's Blood
April 3, 2017: Strategy to enhance activity
Nov. 4, 2016: New AMP kills resistant strains
Sept 22, 2016: Plant AMPs Targets Dental Plaque and Gum Tissues
Jan 5, 2015: Fat Isn't All Bad
Nov 2009: RTD-1 prevents mouse death infected with SARS-CoV
Nov 2007: Human cathelicidin LL-37 inhibits HIV-1